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Abstract
Three polymers, poly(N-(2-hydroxypropyl)methacrylamide) (pHPMA), hyperbranched polyglycerol (hPG), and dextran were
investigated as carriers for multivalent ligands targeting the adaptive tandem WW-domain of formin-binding protein (FBP21).
Polymer carriers were conjugated with 3–9 copies of the proline-rich decapeptide GPPPRGPPPR-NH2 (P1). Binding of the
obtained peptide–polymer conjugates to the tandem WW-domain was investigated employing isothermal titration calorimetry (ITC)
to determine the binding affinity, the enthalpic and entropic contributions to free binding energy, and the stoichiometry of binding
for all peptide–polymer conjugates. Binding affinities of all multivalent ligands were in the µM range, strongly amplified compared
to the monovalent ligand P1 with a KD > 1 mM. In addition, concise differences were observed, pHPMA and hPG carriers showed
moderate affinity and bound 2.3–2.8 peptides per protein binding site resulting in the formation of aggregates. Dextran-based
conjugates displayed affinities down to 1.2 µM, forming complexes with low stoichiometry, and no precipitation. Experimental
results were compared with parameters obtained from molecular dynamics simulations in order to understand the observed differ-
ences between the three carrier materials. In summary, the more rigid and condensed peptide–polymer conjugates based on the
dextran scaffold seem to be superior to induce multivalent binding and to increase affinity, while the more flexible and dendritic
polymers, pHPMA and hPG are suitable to induce crosslinking upon binding.
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Figure 1: Comparing the entropy loss during ligand–receptor interactions in dependence of the rigidity of the backbone.
Introduction
Multivalency is a general principle in nature for increasing the
affinity and specificity of ligand–receptor interactions [1].
Multivalent binding is characterized by the cooperative, over-
additive enhancement of binding affinities of ligands and recep-
tors in a defined spatial arrangement. The strongest affinity
enhancement can be expected in the case of a perfectly fitting,
rigid arrangement of ligands and receptors (Figure 1A). In such
cases the affinity of the multivalent ligand can be potentiated by
the degree of multivalency. Prominent examples for this perfect
fit have been reported reaching an exponential binding increase
[2]. Rigid scaffolds can be used to present ligands in defined
spatial arrangements and thus can be exploited to investigate the
distances between receptor sites as “molecular ruler” [3,4].
Many multivalent receptors in nature, however, are character-
ized by the flexible arrangement of receptor sites and the
resulting relative mobility of binding domains seems to have a
significant impact on the proper functioning of these proteins
[5]. Flexible arrangements of receptor sites can result from
different scenarios. In many proteins flexibility is introduced by
regions of inherent structural mobility, e.g., by so-called
unstructured regions inserted between the receptor domains of a
multireceptor protein. Alternatively, the relative mobility of
binding sites is realized by their embedding into membranes
giving them a certain degree of freedom to move in the plane of
the membrane, or by incorporation into dynamic multiprotein
complexes.
Design of potent multivalent ligands for flexible receptor
arrangements is a considerable challenge, as the flexibility of
multivalent ligands and the flexibility of receptors have to be
matched in order to balance enthalpic gain with entropic loss of
the system. In such a setting, a rigid multivalent ligand binding
to a flexible receptor can be expected to reduce the entropy of
the system upon binding, and thus will result in a partial or
complete loss of the multivalent affinity enhancement. For
example, the targeting of flexible protein receptors with ligands
attached to a rigid DNA-backbone has been reported to be
unsuccessful and no preferred ligand distance was found for this
“molecular ruler” for flexible divalent protein targets [4].
Recently, we have introduced multivalent peptide–polymer
conjugates as a chemical tool to inhibit protein–protein interac-
tions in living cells [6]. As demonstrated for the pro-apoptotic
BH3-peptides, multivalent presentation of monovalent ligand
peptides can potentiate the activity of the peptide at identical
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overall peptide concentrations. Moreover, attachment of bioac-
tive peptides to polymers strongly enhanced their stability and
protected them from proteolysis [7,8]. The construction of
peptide-polymer conjugates with additional cell-penetrating
peptides attached [9] enabled the smooth intracellular delivery
of the conjugated polymer; as a third component fluorescent
dyes [10] were coupled to the polymers simultaneously with the
bioactive and the cell-penetrating peptides in order to enable the
monitoring of cellular uptake and intracellular distribution of
the peptide–polymer conjugate.
Until now, various polymer carriers have been used for the
construction of peptide–polymer conjugates [11,12], however, a
systematic comparison of the different polymeric materials with
respect to the structure–activity relationships is missing so far.
The goal of this contribution is to synthesize and compare flex-
ible multivalent ligands for an adaptive, divalent receptor as a
protein target. As a model protein the tandem-WW-domain of
the pre-mRNA splicing factor formin binding protein 21
(FBP21) was selected [13-15]. Considering the importance of
FBP21 in the activation of RNA splicing, successful ligands
should be valuable tools to interfere with FBP21-dependent
splicing events. Several multivalent ligands were synthesized on
the basis of various polymer supports differing in their chem-
ical structure, backbone flexibility, morphology, and ligand
loading. The obtained materials were then investigated in order
to contribute to the understanding of structure–activity relation-
ships of polymeric ligands. For this purpose, the thermody-
namics and the stoichiometry of protein binding events were
determined experimentally for all multivalent ligands. Finally,
atomistic molecular dynamics simulations were conducted in
order to rationalize the observed differences on a microscopic
level and to derive general principles for the design of opti-
mized multivalent ligands of flexible protein targets.
Results and Discussion
Selection of a bivalent protein receptor as a
target
As a representative example for a protein containing a bivalent
domain architecture connected with a flexible linker the tandem
WW-domains of the protein FBP21 were selected. FBP21 is a
protein component of the spliceosome, the multiprotein com-
plex in the nucleus of cells responsible for the processing of pri-
mary RNA-transcripts. The two WW domains of FBP21 bind to
proline-rich sequences contained in numerous proteins
including the core splicing protein SmB/B´and several splicing
factors including splicing factor 3B4 (SF3B4) [16,17].
Recently, the enhanced binding affinity of bivalent and tetrava-
lent peptide ligands to this protein was described suggesting
that multivalent ligands may play a significant role also in
living cells. In addition, several interaction partners of FBP21
have been profiled by SILAC/MS [18]. As monovalent peptide
ligands for each of the two WW domains proline-rich sequences
(PRS) of the group Rb have been identified, in which the proline
residues are flanked by arginine (R in one-letter-code) [16,19].
Multivalent arrangements of these monovalent ligands there-
fore could serve as potent inhibitors of FBP21-interactions and
could be used for the inhibition of FBP21 function. As a mono-
valent peptide ligand the decapeptide amide GPPPRGPPPR-
NH2 (P1) was selected and synthesized on Rink amide poly-
styrene resin. For attachment to the polymer carriers the
N-cysteinylated peptide CGPPPRGPPPR-NH2 (P2) was
prepared, containing a free N-terminus in order to enable the
attachment to polymers via native chemical ligation or Michael
addition to maleimide residues.
Selection of polymer carriers and synthesis of
multivalent ligands
Three biocompatible polymers with different chemical struc-
ture, backbone flexibility and polymer morphology were
selected as multivalent ligand carriers, two linear polymers and
one dendritic polymer (Scheme 1). Linear poly(N-(2-hydroxy-
propyl)methacrylamide) (pHPMA) possesses a C2 repeating
unit with three fully rotatable bonds, which should convey –
compared to the other polymers employed in this study – high
backbone flexibility to this carrier. Reactive pHPMA was
prepared in a copolymerization of HPMA and the thioester-
containing building block N-methacryloyl-β-alaninyl-S-benzyl
thioester under reversible addition–fragmentation chain-transfer
(RAFT) conditions yielding a thioester-containing copolymer
with 13.3 kDa and polydispersity of 1.2, which we denomi-
nated as NCL-polymer [10]. NCL-polymer was converted into
multivalent peptide–polymer conjugates pHPMA-1 and
pHPMA-2 via native chemical ligation with the N-cysteiny-
lated peptide CGPPPRGPPPR-NH2 (P2). In contrast, the
second carrier molecule, hyperbranched polyglycerol (hPG)
was selected as a dendritic polymer. While the backbone of PG
is relatively flexible by itself, the dendritic structure of hPG can
be expected to limit the flexibility of attached ligands compared
to a linear polymer and might induce a more globular arrange-
ment of the ligands. The hPG polymer carrier was synthesized
via an anionic ring-opening polymerization of glycidol [20] and
also modified with maleimido groups by reaction with N-3-
chloropropyl maleimide for ligand attachment.
Finally, dextran, a polysaccharide containing α-1,6-linked
D-glucose as repeating unit, was selected as the second linear
carrier. The D-glucose units in the polysaccharide are fixed in
the 1C4 chair conformation and thus can be expected to rigidify
the polymer backbone compared to the other two polymers,
leaving only two freely rotatable bonds per building block.
Structural studies with dextran suggested a helical structure as
Beilstein J. Org. Chem. 2015, 11, 837–847.
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Scheme 1: Selection of three polymer carriers differing with respect to backbone flexibility, and morphology and used for the construction of
peptide–polymer conjugates.
the lowest energy conformations of this polymer [21]. Dextran
was used as a linear polymer with an average MW of either
10 kDa (for Dex-1 and Dex-2) or 50 kDa (for Dex-3), both with
a polydispersity index of 1.5. Under basic conditions the linear
polysaccharide was alkylated with acrylamide selectively in the
2-positions of the sugars. The resulting 2-O-carboxyethyl
dextran (2-O-CE-dextran) was further converted by conden-
sation with 2-N-maleimido-ethylamine and N-ethyl-N´-di-
methylaminopropylcarbodiimide (EDC) [6]. The monovalent
ligand peptide 2 was attached to the dextran carriers by nucleo-
Beilstein J. Org. Chem. 2015, 11, 837–847.
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Figure 2: Representative ITC-measurements conducted at 8 °C with the peptide–polymer conjugates A) pHPMA-1 and B) Dex-2 showing an increase
in affinity for the interaction of Dex-2 with the FBP21 tandem WW domains. The upper part shows differential heating power (Δp) changes upon injec-
tion of peptide–polymer conjugates into the protein; bottom part shows integrated and normalized heat of reaction plotted against peptide/protein
molar ratio; binding isotherms are fitted with a 1:1 binding model.
philic addition of the thiols to the maleimide double bond
furnishing peptide–polymer conjugates Dex-1, Dex-2, and
Dex-3.
Peptide loadings of all obtained peptide–polymer conjugates
were determined by quantitative amino acid analysis and ranged
from 3 to 9 peptides per polymer corresponding to peptide
loading densities (percentage of ligand-carrying monomers)
between 3 and 10%.
Binding of multivalent peptide–polymer
conjugate to the tandem WW domain
Binding studies with peptide–polymer conjugates were
conducted employing isothermal titration calorimetry (ITC).
This method enables the determination of the binding affinity of
the multivalent ligands and elucidates the composition of the
free energy of binding from the enthalpic and entropic contribu-
tions. In addition, the method can be used to determine the stoi-
chiometry of the formed protein–ligand complex indicating the
ratio of peptide ligand molecules relative to each protein
binding site thereby giving valuable insights into the multiva-
lency of binding and/or the degree of crosslinking. Thus, the
method enables the identification of polymer–protein aggre-
gates containing several polymers and proteins in a complex.
No precipitation of the multicomponent aggregates that inter-
fered with ITC measurements was observed during the experi-
ments.
ITC-analysis (Figure 2) of the binding of multivalent
peptide–polymer conjugates yielded KD values either corres-
ponding to the polymer concentration or relative to the overall
peptide concentration (N*KD). A comparison of the binding
affinity of the monovalent peptide ligand P1 and its N-acetyla-
ted derivative Ac-P1 with seven multivalent peptide ligands to
the tandem WW-domain revealed a strong enhancement of the
binding through multivalency (Table 1, Figure 3). While the
peptide alone bound with a dissociation constant (KD) of larger
than 1 mM [16], all multivalent peptide-polymer conjugates
possessed KD values below 10 µM. Though all KD values of
multivalent ligands were in the same concentration range (i.e.,
between 1.2 and 7 µM), concise differences were revealed for
the thermodynamic composition of KD values (Figure 2). While
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P1 – 100 > 1000 > 1000 – –
Ac-P1 – 100 >1000 >1000 – –
pHPMA-1 6 (92) 6.5 5.0 ± 0.8 30 ± 5 2.6 X
pHPMA-2 9 (108) 8 3.3 ± 0.6 30 ± 5 2.8 X
hPG-1 3 (97) 3 6.3 ± 1.7 19 ± 5 2.3 X
hPG-2 4 (97) 4 5.0 ± 1.3 20 ± 5 2.4 X
Dex-1 3 (62) 5 7.0 ± 1.2 21 ± 4 1.8 –
Dex-2 6 (62) 10 1.2 ± 0.7 7 ± 4 1.4 –
Dex-3 8 (248) 3 1.6 ± 0.4 13 ± 3 1.3 –
aDextran, hyperbranched PG and poly(HPMA) coupled with the N-cysteinylated peptide CGPPPRGPPPR (P2); bN: number of ligands (number of
repeating units in the polymeric scaffolds); cbinding affinities of peptide–polymer conjugates; dbinding affinities measured by ITC related to overall
peptide concentrations.
the ligands based on polymethacrylamide displayed moderate
enthalpic and almost negligible entropic contributions , all poly-
hydroxy-based peptide–polymer conjugates showed signifi-
cantly stronger generation of heat through binding (enthalpy)
together with a pronounced loss in entropy. Binding in all cases
was driven mainly by enthalpy, which clearly outweighed the
observed entropy loss. In the seven peptide–polymer conju-
gates investigated, increased loading density of ligands led
consistently to increased affinity of the multivalent ligand
(Table 1). The most significant difference between dextran and
the two other polymer carriers was the stoichiometry of the
formed peptide-polymer–protein complex. Inspection of the test
solution revealed the formation of a colloidal suspension/disper-
sion both for pHPMA and for hPG-based peptide conjugates
indicating the formation of insoluble aggregates possibly gener-
ated through crosslinking. Corresponding to the observed
colloidal suspension/dispersion the stoichiometry of peptide
ligands per protein receptor resulting from the ITC experiments
was >2 for each of either pHPMA or hPG-based material, most
pronounced for pHPMA with n = 2.6–2.8. Dextran-based conju-
gates displayed a ligand stoichiometry of 1.4 for the most potent
multivalent ligand with a KD of 1.2 µM, Dex-2. No correlation
between ligand density and stoichiometry became evident from
the recorded data, however, the observed correlation between
low binding stoichiometry, increased binding affinity, and
increased binding enthalpy seems to suggest the prevalence of a
bivalent binding mode for the complex of Dex-2 and tandem-
WW-FBP21, which is supported also by the solubility of the
non-crosslinked peptide-polymer–protein complex.
Molecular dynamics simulations of multiva-
lent ligands
In order to better understand our experimental observations
regarding binding affinities, enthalpic/entropic energy contribu-
Figure 3: Enthalpic and entropic contributions to the free energy of
binding processes of multivalent peptide-polymer conjugates and the
tandem WW domain of protein FBP21 determined at 8 °C by ITC
measurements.
tions, and binding stoichiometries from a molecular point of
view, the three polymer carriers were investigated using atom-
istic molecular dynamics simulations. Each polymer was repre-
sented by one model parameterized in accordance with the
AMBER force field [22]. The concentration ratios of peptide
ligands and monomeric units were fit to lab conditions such that
each polymer was carrying three ligands. In contrast to the
linear polymer models of dextran and pHPMA with 10 and 12
units between any two successive ligands, respectively, the hPG
configuration was generated randomly with the aid of a proba-
bilistic hPG building algorithm as described previously [23].
After some preparatory relaxation steps, each of the three poly-
mers underwent three explicit solvent molecular dynamics
Beilstein J. Org. Chem. 2015, 11, 837–847.
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Table 2: Molecular dynamics simulations of the protein target and the multivalent polymeric ligands.
Polymeric scaffold pHPMA hPG Dextran
Mean distance (expected value) rdf [nm]a 1.41 1.56 1.23
Peptide distance at binding site [nm]b 0,84 0,48 0,43
Peptide distance at the termination site [nm]c 3,39 3,66 2,9
E(peptide-polymer) [kJ/mol]d −515,3 −783,3 −912,7
E(peptide-solution) [kJ/mol]e −3268,7 −3224,8 −3281,1
Globularityf 0,037 0,104 0,066
aExpected mean distance values (calculated by a radial distribution function); mean distance between two peptide ligands on a polymer chain
measured between bthe N-terminal sulfur atoms of the Cys-residues at their linking site and cthe C-terminal nitrogen atoms of the Arg residue as the
farthest distance between peptide and polymer backbone; average potential energy regarding dthe affinity of the peptide to the polymer and ethe
solvation energy of the peptide; fratio of the peptide-polymer conjugates volume and the appropriate sphere.
(MD) simulations of 100 ns length serving as production runs.
The first 30% of the time steps were considered as an unre-
stricted equilibration phase and consequently omitted whereas
from the remaining time series several promising structural and
physical descriptors were determined. For all simulations and
analytical calculations the Gromacs software suite was utilized
[24]. Table 2 and Figure 4 show these theoretical results aver-
aged over time as well as the three runs per polymer.
Structural properties and descriptors. Dividing the
Euklidean distance between two successive peptide attachment
points by the number of bonds in between (i.e., between the
N-terminal nitrogen atoms of the cysteinylated peptide P2 in the
case of pHPMA, and the Cys-sulfur in the cases of both hPG
and dextran) yields relative distances which indicate that the
peptide ligands in pHPMA are further apart than in dextran and
hPG, while the variance of the peptide positions in pHPMA is
higher than in the two hydroxyl polymers (Table 2, Figure 4A).
Next, we were interested in the distances between the
C-terminal positions of the peptide ligands measured between
the C-terminal amide nitrogens of the peptides (Table 2,
Figure 4B). Here, the peptides on dextran were found to be
closer (2.9 nm) to each other than in pHPMA (3.4) and hPG
(3.7 nm). The larger distance in hPG might be related to the
hypervalent morphology of this carrier, which possibly limits
the proximity of attached ligands. Expected values of averaged
(over time and atoms) radial distributions (correlating with
normalized mean distances) of polymer atoms around peptide
atoms clearly reveal a higher polymer-peptide proximity for the
dextran system (1.23 nm) than for pHPMA (1.41 nm) and hPG
(1.56 nm). Considering the statistical character of the under-
lying molecular ensemble, the time-averaged radial distribution
function (rdf) values indicate a smaller ratio of the fraction of
time steps with outstretched peptides (which are more acces-
sible for binding with the tWW domain) and the fraction of time
steps characterized by a contracted structure in case of peptides
associated with the dextran polymer (Figure 4C). Thus, ligands
attached to pHPMA or hPG are more often available for protein
binding than those linked to dextran. As a consequence,
multiple simultaneously outstretched peptides are even less
likely to emerge in case of dextran in comparison with the other
polymers. Moreover, after having bound the first protein and
due to substantially smaller peptide end-to-end distances given
with dextran, its next outstreched peptide will rather bind a free
tWW domain of the same protein than of another one which
clearly confirms the stoichiometric results. This binding mode
is illustrated in Figure 5.
Another descriptor for the spatial arrangement that we denote as
the peptide polymer's globularity was defined as the quotient of
the volume under the multivalent ligand's solvent-accessible
surface area (SASA) and the volume of the minimal sphere
incorporating the entire molecule (Table 2). Not unexpectedly,
the conformation of the peptide conjugate with the dendritic
polymer hPG yields a significantly higher globularity (0.1)
compared to those associated with pHPMA (0.04) or dextran
(0.07). Regarding these two linear carriers only, the higher
globularity of the dextran-based ligand is in good agreement
with that material's peptide–polymer distance.
Thermodynamic properties. From a physical point of view,
the significantly varying mean peptide–peptide and
peptide–polymer distances are mainly attributed to molecular
interactions between the involved atoms. For this reason we
calculated non-bonded interaction energies between peptide
atoms and both polymer and solvent atoms as the sum of van-
der-Waals and electronic contributions (Table 2) While the
interaction energies between peptides and solvents are, as
expected, nearly identical for all three systems, the interaction
of peptide atoms regarding polymer atoms amounts to substan-
tially different values for the three carrier materials. With
−913 kJ/mol dextran yielded the by far lowest energy compared
with those peptides attached to the two high-stoichiometry poly-
mers (−515 kJ/mol and −783 kJ/mol). Since lower energies
Beilstein J. Org. Chem. 2015, 11, 837–847.
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Figure 4: MD simulations over time (0–100 ns) yielding A) the mean sulfur distance between two peptides at their linking site, B) the mean nitrogen
distance between two peptides at the farthest distance between peptide and polymer chain C) the frequency of observed peptide–polymer distances
in dependence of the polymer backbone pHPMA, hPG and dextran, respectively.
correspond to preferential states, the interaction energy can be
interpreted as a measure for a state's preference. In general,
preferential states are characterized by (negative-signed) attrac-
tive forces dominating over (positive-signed) repulsive forces.
Hence, according to these results, the peptide is more attracted
by the dextran carrier than by the two others most likely causing
the small expected polymer–peptide distance and possibly the
small peptide end-to-end distances in case of dextran.
Finally, the molecular dynamics simulations of the
peptide–polymer conjugates were compared with those of
dimeric complexes with a bivalent binding mode in order to
calculate the entropic loss of both the protein and of the
peptide–polymer conjugates themselves (Table 3). Interestingly,
in all three cases the major contribution to the entropic loss was
on the side of the protein, the decrease in entropy on the
polymer side was comparably small. Though bivalent binding
Beilstein J. Org. Chem. 2015, 11, 837–847.
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Figure 5: MD simulation image showing the interaction of two dextran–peptide conjugates with three tandem WW domains of FBP21 illustrating the
intramolecular mode of binding.
modes are strongly favoured through enthalpic gain, the free
energy gain is limited by the entropy loss, most likely caused by
the flexibility of the linker and thus a larger number of alter-
native conformational states of the protein receptor.
Conclusion
All three investigated biocompatible polymers, namely linear
poly(N-2-hydroxypropyl)methacrylamide (pHPMA), hyper-
branched polyglycerol (hPG), and linear 2-carboxyethyldextran
are suited for the construction of peptide–polymer conjugates,
Table 3: Calculated changes in entropy during binding of the multiva-
lent polymeric ligands to the bivalent receptor by molecular dynamics
simulations.
Binding partner Entropy contribution TΔS [kJ/mol]
pHPMA hPG dextran
Protein receptor −14.91 −15.20 −14.74
Polymeric ligand −0.67 −1.38 −0.92
Σ −15.58 −16.58 −15.66
Beilstein J. Org. Chem. 2015, 11, 837–847.
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which can be used as potent multivalent ligands for a flexible
protein–protein interaction site here exemplified by the tandem
WW-domains of FBP-21. 2-Carboxyethyldextran furnished
peptide–polymer conjugates with significantly higher binding
affinity than the two other carriers. The observed binding modes
of the three carriers were distinct. Dextran-based conjugates
formed preferably bivalent, soluble complexes with a stoi-
chiometry of <2 peptide ligands per protein binding site, while
pHPMA and hPG formed colloidal suspensions/dispersions
with stoichiometries >2 ligands per binding site. Molecular
dynamics calculations suggested that conjugates with multiva-
lently presented peptides on dextran occupy conformations
in which two conjugated peptides are closer to each other and to
the polymer backbone, corresponding to the calculated stronger
peptide-polymer interaction. From the study it can be supposed
that the simulated conformational space of the investigated
peptide–polymer conjugates indeed correlates with
the experimentally observed binding properties of the multiva-
lent ligands. The construction and experimental investigation of
further peptide–polymer conjugates will show, whether the
results reported here will be helpful for the construction of even
more potent multivalent and/or crosslinking ligands for
protein–protein interaction sites and whether the ligands active
in the protein binding assay can be further developed toward
intracellularly delivered and intracellularly active PPI-inhibi-
tors of the tandem WW-domain.
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